A gene that scientific dogma insists is inactive in adults actually plays a vital role in preventing the underlying cause of most heart attacks and strokes, researchers at the University of Virginia School of Medicine have determined. The discovery opens a new avenue for battling those deadly conditions, and it raises the tantalizing prospect that doctors could use the gene to prevent or delay at least some of the effects of aging.
“Finding a way to augment the expression of this gene in adult cells may have profound implications for promoting health and possibly reversing some of the detrimental effects with aging,” said researcher Gary K. Owens, PhD, director of UVA’s Robert M. Berne Cardiovascular Research Center.
Unexpected Protective Effect
The gene, Oct4, plays a key role in the development of all living organisms, but scientists have, until now, thought it was permanently inactivated after embryonic development. Some controversial studies have suggested it might have another function later in life, but the UVA researchers are the first to provide conclusive evidence of that: Owens and his colleagues have determined the gene plays a critical protective role during the formation of atherosclerotic plaques inside blood vessels. The rupturing of these plaques is the underlying cause of many heart attacks and strokes.
The researchers found that Oct4 controls the movement of smooth muscle cells into protective fibrous “caps” inside the plaques – caps that make the plaques less likely to rupture. The researchers also have provided evidence that the gene promotes many changes in gene expression that are beneficial in stabilizing the plaques.
This is exciting, because studies suggest that it may be possible to develop drugs or other therapeutic agents that target the Oct4 pathway as a means to reduce the incidence of heart attacks or stroke. “Our findings have major implications regarding possible novel therapeutic approaches for promoting stabilization of atherosclerotic plaques,” said Olga A. Cherepanova, PhD, a senior research scientist in Owens’ lab.
One surprising finding from UVA’s research: When the researchers blocked the effect of Oct4 in mice, they thought the atherosclerotic plaques might become smaller, because of the reduced number of smooth muscle cells inside. Instead, the plaques grew larger, less stable and more dangerous, stuffed with lipids, dead cells and other damaging components.
Advancing Regenerative Medicine
While UVA’s research has focused on how Oct4 offers cardiovascular protection, Owens and his colleagues believe the gene could also prove critical to the field of regenerative medicine, which investigates the growth and replacement of tissues and organs. The researchers believe that Oct4 and its family of target genes are activated in other somatic cells – the non-reproductive cells in the body – and play a key role in the cells’ ability to repair damage and heal wounds. Studies to test this are under way in Owens’ lab.
Oct4 is one of the “stem cell pluripotency factors” described by Shinya Yamanaka, MD, PhD, for which he received the 2012 Nobel Prize. His lab and many others have shown that artificial over-expression of Oct4 within somatic cells grown in a lab dish is essential for reprogramming these cells into induced pluripotential stem cells, which can then develop into any cell type in the body or even an entire organism.
The UVA researchers suspect that at least some of the detrimental effects of aging, including the increased possibility of a plaque rupture, stem from a decrease in the body’s ability to reactivate Oct4. “Finding a way to reactivate this pathway may have profound implications for health and aging,” Owens said. “We think this is just the tip of the iceberg for controlling plasticity of somatic cells, and this could impact many human diseases and the field of regenerative medicine. Who knows, this may end up being the ‘fountain-of-youth gene,’ a way to revitalize old and worn-out cells. Only time will tell.”
The Latest on: Oct4 gene
via Google News
The Latest on: Oct4 gene
- Price tag on gene therapy for rare form of blindness: $850Kon January 2, 2020 at 4:00 pm
FILE - In this Oct. 4, 2017, file photo, Dr. Albert Maguire, right, checks the eyes of Misa Kaabali, 8, at the Children's Hospital of Philadelphia. Misa was 4-years-old when he received his gene ...
- Recalling those who died in 2019on December 31, 2019 at 4:18 pm
Here is a roll call of some influential figures who died in 2019 (cause of death cited for younger people, if available): Eugene “Mean Gene” Okerlund, 76. His deadpan interviews of pro ...
- Final goodbye: Recalling notable people who died in 2019on December 26, 2019 at 4:22 pm
Here is a roll call of some influential figures who died in 2019 (cause of death cited for younger people, if available): Eugene "Mean Gene" Okerlund, 76. His deadpan interviews of pro wrestling ...
- Assailing Columbus, VR for seniors, otter attack: News from around our 50 stateson October 14, 2019 at 11:40 pm
If a person has an incorrect word – or, in this case, a gene – the technology will identify ... The white gators were introduced to their new digs Oct. 4. Leucistic gator Trezos hesitated ...
- At AdventHealth Wesley Chapel, groups focus on the silent post-cancer battleon October 4, 2019 at 2:04 am
The Oct. 4 weekly edition of the Tampa Bay Business Journal ... especially as she never had the cancer gene. But she continues on, keeping her thoughts focused on her family.
- On the Road: Wyoming Golfers Have Two Tournaments in Five-Day Stretchon October 2, 2019 at 5:00 pm
Starzinski tied for 20th at the Gene Miranda and tied for 16th at the ... The teams will play one 18-hole round each on Friday, Oct. 4, Saturday, Oct. 5 and Sunday, Oct. 6.
- Gene Therapy Can Help Boys With ‘Lorenzo’s Oil’ Diseaseon September 1, 2019 at 5:00 pm
Study results published Wednesday, Oct. 4, 2017, by the New England Journal of Medicine showed an experimental gene therapy treatment seemed to help boys with the inherited nerve disease featured ...
- Research identifies super-enhancers as novel target for pancreatic ductal adenocarcinomaon February 28, 2019 at 11:05 pm
Differential H3K27AC marks were identified at enhancer regions of genes including c-MYC, MED1, OCT-4, NANOG, and SOX2 that can act as super-enhancers (SE), cluster of genes in non-cancerous ...
- Hitting the Reset Button on Aging Cellson February 17, 2019 at 4:00 pm
Takahashi and Yamanaka showed that it was possible to reprogram cells using just four master genes named oct4, sox2, klf4, and c-myc, or OSKM for short . Prior to this, it was assumed that egg ...
- Stem Cells Made by Modifying the Epigenome with CRISPRon January 25, 2018 at 12:46 pm
“This paper demonstrates the ability of CRISPR effectors to go beyond turning on a single gene and completely rewire the transcriptional state of the cell,” Neville Sanjana, a bioengineer at the New ...
via Bing News